long half-life and large variability [Regulatives / Guidelines]

posted by dshah  – India/United Kingdom, 2020-08-10 08:18 (1341 d 07:15 ago) – Posting: # 21846
Views: 2,317

Hi All!

I believe there are few MR drug with high variability and still USFDA recommends partial or fully replicate design. Mesalamine PSG or
Mesalamine PSG for 800 mg strength
Considering the Mechanism of Action, PK variability, non-Linearity- the study and formultion could indeed be challenging.

Regards,
Dshah

Complete thread:

UA Flag
Activity
 Admin contact
22,980 posts in 4,821 threads, 1,659 registered users;
41 visitors (0 registered, 41 guests [including 15 identified bots]).
Forum time: 15:33 CEST (Europe/Vienna)

Never, never, never use any software!
Never, never, never trust any computer!    Detlew Labes

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5